Legislation





Current Lyme Disease Legislation in Maine


STATE OF MAINE
___________
IN THE YEAR OF OUR LORD
TWO THOUSAND AND FIFTEEN
___________
H.P. 289 – L.D. 422

An Act To Improve Access to Treatments for Lyme Disease
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 32 MRSA §3282-B is enacted to read:
§ 3282-B. Lyme disease treatment

1. Definitions. As used in this section, unless the context otherwise indicates, the following terms
have the following meanings.
A. "Long-term antibiotic therapy" means the administration of oral, intramuscular or intravenous
antibiotics, singly or in combination, for a period of time in excess of 4 weeks.
B. "Lyme disease" means:
(1) The presence of signs or symptoms compatible with acute infection with Borrelia burgdorferi;
(2) Late stage, persistent or chronic infection with Borrelia burgdorferi;
(3) Complications related to an infection under subparagraph (1) or (2); or
(4) The presence of signs or symptoms compatible with acute infection or late stage, persistent or
chronic infection with other strains of Borrelia that are identified or recognized by the United
States Department of Health and Human Services, Centers for Disease Control and Prevention as
a cause of disease.
"Lyme disease" includes an infection that meets the surveillance criteria for Lyme disease established by
the federal Centers for Disease Control and Prevention or a clinical diagnosis of Lyme disease that does
not meet the surveillance criteria for Lyme disease set by the federal Centers for Disease Control and
Prevention but presents other acute and chronic signs or symptoms of Lyme disease as determined by a
patient's treating physician.

2. Lyme disease treatment. A physician licensed under this chapter may prescribe, administer or
dispense long-term antibiotic therapy for a therapeutic purpose to eliminate infection or to control a
patient's symptoms upon making a clinical diagnosis that the patient has Lyme disease or displays
symptoms consistent with a clinical diagnosis of Lyme disease. The physician shall document the
clinical diagnosis and treatment in the patient's medical record. The clinical diagnosis must be based on
knowledge obtained through medical history and physical examination only or in conjunction with
testing that provides supportive data for the clinical diagnosis.




Recently Enacted Legislation Regarding Lyme Disease and Tick-borne illness
Public Law, Chapter 561, LD 2157, item 1, 123rd Maine State Legislature:  An Act to Implement the Recommendations of the Joint Standing Committee on Insurance and Financial Services Regarding Reporting on Lyme Disease and Other Tick-borne Illnesses (http://www.mainelegislature.org/legis/bills/bills_123rd/chappdfs/PUBLIC561.pdf)
  • Requires an annual Lyme Legislative report - 2015 Report
Resolve, Chapter 143 LD 1521, item 1, 123rd Maine State Legislature:  Resolve, To Provide Education Concerning and Insurance Coverage for Lyme Disease (http://www.mainelegislature.org/legis/bills/bills_123rd/chappdfs/RESOLVE143.pdf)
  • Encourages public education for Lyme disease
Public Law, Chapter 494 LD 1709, item 1, 124th Maine State Legislature:  An Act to Enhance Public Awareness of Lyme Disease (http://www.mainelegislature.org/legis/bills/bills_124th/chappdfs/PUBLIC494.pdf)
Public Law, Chapter 340, LD 597, 126th Maine State Legislature:  An Act to Inform Persons of the Options for the Treatment of Lyme Disease (http://www.mainelegislature.org/legis/bills/getPDF.asp?paper=HP0416&item=12&snum=126)
  • Acknowledges difficulty in diagnosing and treating Lyme disease
  • Information on risks of long term antibiotic therapy